Current practices in the management of adenovirus infection in allogeneic hematopoietic stem cell transplant recipients in Europe: The AdVance study.
Fiche publication
Date publication
mars 2019
Journal
European journal of haematology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr POCHON Cécile
Tous les auteurs :
González-Vicent M, Verna M, Pochon C, Chandak A, Vainorius E, Brundage T, Mozaffari E, Nichols G, Rao K
Lien Pubmed
Résumé
Adenovirus (AdV) infections are potentially life-threatening for allogeneic hematopoietic stem cell transplant (allo-HCT) recipients. The AdVance study aimed to evaluate the incidence, management, and outcomes of AdV infections in European allo-HCT recipients.
Mots clés
DNA viruses, adenoviridae, antiviral agents, infection control, transplantation, virus diseases
Référence
Eur J Haematol. 2019 Mar;102(3):210-217